PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7 Meeting Abstract


Authors: Kunimoto, H.; Honma, D.; Tsutsumi, S.; Sakuma, T.; Ohashi, T.; Teranaka, H.; Ikeda, J.; Toya, T.; Harada, Y.; Doki, N.; Cai, S.; Yoshimi, A.; Goto, H.; Levine, R.; Nakajima, H.
Abstract Title: PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7
Meeting Title: Cancer Sci.
Journal Title: Cancer Science
Volume: 116
ISSN: 1347-9032
Publisher: Wiley Blackwell  
Date Published: 2025-01-01
Start Page: 850
End Page: 850
Language: English
ACCESSION: WOS:001401044102103
PROVIDER: wos
DOI: 10.1111/cas.16413
Notes: Meeting Abstract -- SI -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics